Table 2.
Delivery Outcomes
| Amlodipine (n=48) | Other Antihypertensives (n=54) | No Antihypertensives (n=129) | P Value | |
|---|---|---|---|---|
| Maternal outcomes | ||||
| Superimposed preeclampsia, N (%) | 15 (31.3) | 14 (25.9) | 43 (33.3) | 0.615 |
| Gestational diabetes mellitus, N (%) | 3 (6.3) | 8 (14.8) | 24 (18.6) | 0.125 |
| Newborn outcomes | ||||
| Gestational age, wks—mean (SD) | 37.7 (2.14) | 36.9 (3.43) | 37.1 (3.65) | 0.417 |
| Delivery weight, g—mean (SD) | 2778.4 (619.54) | 2520.1 (800.09) | 2536.0 (759.40) | 0.123 |
| Preterm birth (<37 wks), N (%) | 10 (20.8) | 12 (22.2) | 41 (31.8) | 0.221 |
| Low birth weight (<2500 g), N (%) | 12 (25.0) | 24 (44.4) | 49 (38.0) | 0.116 |
| Apgar score | ||||
| 1 min, mean (SD) | 8.0 (0.99) | 7.4 (1.97) | 7.6 (1.69) | 0.165 |
| 5 min, mean (SD) | 8.9 (0.43) | 8.5 (1.30) | 8.7 (1.22) | 0.203 |
| Birth defects, N (%) | 2 (4.2) | 3 (5.6) | 6 (4.7) | 0.944 |
There was no statistically significant difference among the groups.